FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul Moayyedi

Research Profile

Disorders

Living Beings

Helicobacter pylori

Concepts & Ideas

Chemicals & Drugs

Procedures

Activities & Behaviors

Cost Benefit Analysis

Co-author Network

Publications

TOP 3
Paul Moayyedi
Dyspepsia.
B E Lacy; G Richard Locke; Paul Moayyedi; B P Abraham; Ernest P Bouras; J K DiBaise; Hashem B El-Serag; Colin W Howden; Nicholas J Talley; Charlene M Prather
Review article: current treatment options and management of functional dyspepsia.
Alexander C Ford; David Forman; Anthony T R Axon; Alastair G Bailey; Paul Moayyedi
Effect of dyspepsia on survival: a longitudinal 10-year follow-up study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul Moayyedi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Paul Moayyedi
Dyspepsia.
Current opinion in gastroenterology 2012;28(6):602-7.
2012: B E Lacy; G Richard Locke; Paul Moayyedi; B P Abraham; Ernest P Bouras; J K DiBaise; Hashem B El-Serag; Colin W Howden; Nicholas J Talley; Charlene M Prather
Review article: current treatment options and management of functional dyspepsia.
Alimentary pharmacology & therapeutics 2012;36(1):3-15.
2012: Alexander C Ford; David Forman; Anthony T R Axon; Alastair G Bailey; Paul Moayyedi
Effect of dyspepsia on survival: a longitudinal 10-year follow-up study.
The American journal of gastroenterology 2012;107(6):912-21.
2012: Nicholas J Talley; Bincy P Abraham; Ernest P Bouras; Darren M Brenner; John K DiBaise; Hashem B El-Serag; Linda M Herrick; Colin W Howden; Brian E Lacy; G Richard Locke; Paul Moayyedi; Charlene M Prather; Vickie M Silvernail; Alan R Zinsmeister
Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics.
Contemporary clinical trials 2012;33(3):523-33.
2012: Alexander C Ford; Stephen B Hanauer; Khurram J Khan; William J Sandborn; Paul Moayyedi
Efficacy of topical 5-aminosalicylates in preventing relapse of quiescent ulcerative colitis: a meta-analysis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2012;10(5):513-9.
2012: Janusz Jankowski; Hugh Barr; Paul Moayyedi
Does aspirin really reduce the risk of colon cancer?
Lancet 2012;379(9826):1586-7; author reply 1587.
2012: Zain Kassam; Paul Moayyedi; Mark Crowther
Iron overload in human disease.
The New England journal of medicine 2012;366(16):1549; author reply 1549-50.
2012: Paul Moayyedi; Grigorios I Leontiadis
The risks of PPI therapy.
Nature reviews. Gastroenterology & hepatology 2012;9(3):132-9.
2012: Alexander C Ford; Khurram J Khan; Jean-Paul Achkar; Paul Moayyedi
Efficacy of oral vs. topical, or combined oral and topical 5-aminosalicylates, in Ulcerative Colitis: systematic review and meta-analysis.
The American journal of gastroenterology 2012;107(2):167-76; author reply 177.
2012: Mohamad Alshurafa; Neera Bhatnagar; Matthias Briel; Stephen J Gentles; Ted Haines; Francois Lamontagne; Paul Moayyedi; Lorena Rios; Chau Tran; Stephen D Walter; Elie A Akl; Gordon H Guyatt
Inconsistent definitions for intention-to-treat in relation to missing outcome data: systematic review of the methods literature.
PloS one 2012;7(11):e49163.
2012: Waleed Alhazzani; Mohammed Alshahrani; Paul Moayyedi; Roman Jaeschke
Stress ulcer prophylaxis in critically ill patients: review of the evidence.
Polskie Archiwum Medycyny Wewnętrznej 2012;122(3):107-14.
2011: Alexander C Ford; Sunanda V Kane; Khurram J Khan; William J Sandborn; Paul Moayyedi
Once-daily dosing vs. conventional dosing schedule of mesalamine and relapse of quiescent ulcerative colitis: systematic review and meta-analysis.
The American journal of gastroenterology 2011;106(12):2070-7; quiz 2078.
2011: Paul Moayyedi
Helicobacter pylori eradication for functional dyspepsia: what are we treating?: comment on "Helicobacter pylori eradication in functional dyspepsia".
Archives of internal medicine 2011;171(21):1936-7.
2011: Henit Yanai; Laura Yun; Charles N Bernstein; Jeffrey Brooks; Leyla Ghazi; Oscar Lebwohl; Paul Moayyedi; Udayakumar Navaneethan; Geoffrey C Nguyen; Christian D Stone; Shomron Ben-Horin
Practice of gastroenterologists in treating flaring inflammatory bowel disease patients with clostridium difficile: antibiotics alone or combined antibiotics/immunomodulators?
Inflammatory bowel diseases 2011;17(7):1540-6.
2011: Janusz Jankowski; Hugh Barr; John deCaestecker; Peter Watson; Stephen Attwood; Paul Moayyedi
Aspirin in the prevention of cancer.
Lancet 2011;377(9778):1649-50; author reply 1651-2.
2011: Nicholas J Talley; Maria Abreu; Jean-Paul Achkar; Charles N Bernstein; Marla C Dubinsky; Stephen B Hanauer; Sunanda V Kane; William J Sandborn; Thomas A Ullman; Paul Moayyedi
An evidence-based systematic review on medical therapies for inflammatory bowel disease.
The American journal of gastroenterology 2011;106 Suppl 1():S2-25; quiz S26.
2011: Alexander C Ford; Sunanda V Kane; Khurram J Khan; Jean-Paul Achkar; Nicholas J Talley; John K Marshall; Paul Moayyedi
Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis.
The American journal of gastroenterology 2011;106(4):617-29.
2011: Alexander C Ford; Jean-Paul Achkar; Khurram J Khan; Sunanda V Kane; Nicholas J Talley; John K Marshall; Paul Moayyedi
Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis.
The American journal of gastroenterology 2011;106(4):601-16.
2011: Khurram J Khan; Thomas A Ullman; Alexander C Ford; Maria Abreu; Amir Abadir; John K Marshall; Nicholas J Talley; A Abadir; Paul Moayyedi
Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.
The American journal of gastroenterology 2011;106(4):661-73.
2011: Khurram J Khan; Marla C Dubinsky; Alexander C Ford; Thomas A Ullman; Nicholas J Talley; Paul Moayyedi
Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
The American journal of gastroenterology 2011;106(4):630-42.
2011: Alexander C Ford; William J Sandborn; Khurram J Khan; Stephen B Hanauer; Nicholas J Talley; Paul Moayyedi
Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
The American journal of gastroenterology 2011;106(4):644-59, quiz 660.
2011: Alexander C Ford; Charles N Bernstein; Khurram J Khan; Maria Abreu; John K Marshall; Nicholas J Talley; Paul Moayyedi
Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis.
The American journal of gastroenterology 2011;106(4):590-9; quiz 600.
2011: Paul Moayyedi; Alexander C Ford
Symptom-based diagnostic criteria for irritable bowel syndrome: the more things change, the more they stay the same.
Gastroenterology clinics of North America 2011;40(1):87-103.
2011: Alexander C Ford; Khurram J Khan; Nicholas J Talley; Paul Moayyedi
5-aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis.
The American journal of gastroenterology 2011;106(3):413-20.
2011: Paul Moayyedi; Jose Santana; Mostafiz Khan; Cathy Preston; Clare Donnellan
WITHDRAWN: Medical treatments in the short term management of reflux oesophagitis.
Cochrane database of systematic reviews (Online) 2011;(2):CD003244.
2011: Shelly Soo; Paul Moayyedi; Jonathan J Deeks; Brendan Delaney; Maxine Lewis; David Forman
WITHDRAWN: Psychological interventions for non-ulcer dyspepsia.
Cochrane database of systematic reviews (Online) 2011;(2):CD002301.
2011: Paul Moayyedi; Shelly Soo; Jonathan J Deeks; Brendan Delaney; Adam Harris; Michael Innes; R Oakes; Sue Wilson; A Roalfe; Cathy Bennett; David Forman
WITHDRAWN: Eradication of Helicobacter pylori for non-ulcer dyspepsia.
Cochrane database of systematic reviews (Online) 2011;(2):CD002096.
2011: Paul Moayyedi; Soo Shelly; Jonathan J Deeks; Brendan Delaney; Michael Innes; David Forman
WITHDRAWN: Pharmacological interventions for non-ulcer dyspepsia.
Cochrane database of systematic reviews (Online) 2011;(2):CD001960.
2010: Luigi Gatta; Paul Moayyedi; Cesare Tosetti; Nimish Vakil; Enzo Ubaldi; Patrizia Barsanti; Giulia Fiorini; Valentina Castelli; Carlo Gargiulo; Paolo Lucarini; Maurizio Lera; Enkleda Kajo; Francesco Di Mario; Dino Vaira
A validation study of the Italian Short-Form Leeds Dyspepsia Questionnaire.
Internal and emergency medicine 2010;5(6):501-6.
2010: Paul Moayyedi; David Armstrong; Richard H Hunt; Yao Lei; Margaret Bukoski; Robert J White
The gain in quality-adjusted life months by switching to esomeprazole in those with continued reflux symptoms in primary care: EncomPASS--a cluster-randomized trial.
The American journal of gastroenterology 2010;105(11):2341-6.
2010: Alexander C Ford; Avantika Marwaha; Allen Lim; Paul Moayyedi
What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2010;8(10):830-7, 837.e1-2.
2010: Alexander C Ford; Paul Moayyedi
Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome.
Alimentary pharmacology & therapeutics 2010;32(2):144-58.
2010: John K Marshall; Marroon Thabane; Amit X Garg; William F Clark; Paul Moayyedi; Stephen M Collins
Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery.
Gut 2010;59(5):605-11.
2010: Alexander C Ford; Marroon Thabane; Stephen M Collins; Paul Moayyedi; Amit X Garg; William F Clark; John K Marshall
Prevalence of uninvestigated dyspepsia 8 years after a large waterborne outbreak of bacterial dysentery: a cohort study.
Gastroenterology 2010;138(5):1727-36; quiz e12.
2010: Alexander C Ford; Avantika Marwaha; Allen Lim; Paul Moayyedi
Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2010;8(5):401-9.
2010: Alexandra-Chloé Villani; Mathieu Lemire; Marroon Thabane; Alexandre Belisle; Geneviève Geneau; Amit X Garg; William F Clark; Paul Moayyedi; Stephen M Collins; Denis Franchimont; John K Marshall
Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis.
Gastroenterology 2010;138(4):1502-13.
2010: Loren Laine; Brennan Spiegel; Alaa Rostom; Paul Moayyedi; Ernst J Kuipers; Marc Bardou; Joseph Sung; Alan N Barkun
Methodology for randomized trials of patients with nonvariceal upper gastrointestinal bleeding: recommendations from an international consensus conference.
The American journal of gastroenterology 2010;105(3):540-50.
2010: Alexander C Ford; Paul Moayyedi
"Power" of selective serotonin reuptake inhibitors in irritable bowel syndrome.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2010;8(3):313-4; author reply 314.
2010: Paul Moayyedi; A C Ford; Nicholas J Talley; F Cremonini; A E Foxx-Orenstein; Lawrence J Brandt; E M M Quigley
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review.
Gut 2010;59(3):325-32.
2010: Paul Moayyedi; Alexander C Ford; Eamonn M M Quigley; Amy E Foxx-Orenstein; William Chey; Nicholas J Talley; Lawrence J Brandt
The American College of Gastroenterology irritable bowel syndrome monograph: translating systematic review data to clinical practice.
Gastroenterology 2010;138(2):789-91; author reply 791-2.
2010: Alexander C Ford; Gordon H Guyatt; Nicholas J Talley; Paul Moayyedi
Errors in the conduct of systematic reviews of pharmacological interventions for irritable bowel syndrome.
The American journal of gastroenterology 2010;105(2):280-8.
2010: Paul Moayyedi; Janusz A Jankowski
Does long term aspirin prevent cancer?
BMJ (Clinical research ed.) 2010;341():c7326.
2010: Aravamuthan Sreedharan; Janet Martin; Grigorios I Leontiadis; Stephanie Dorward; Colin W Howden; David Forman; Paul Moayyedi
Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding.
Cochrane database of systematic reviews (Online) 2010;(7):CD005415.
2010: Clare Donnellan; Cathy Preston; Paul Moayyedi; Nav Sharma
WITHDRAWN: Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease.
Cochrane database of systematic reviews (Online) 2010;(2):CD003245.
2010: Jay Luther; Peter Higgins; Philip Schoenfeld; Paul Moayyedi; Nimish Vakil; William Chey
Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability.
The American journal of gastroenterology 2010;105(1):65-73.
2009: Paul Moayyedi; Peter Malfertheiner
Editorial: Sequential therapy for eradication of Helicobacter pylori: a new guiding light or a false dawn?
The American journal of gastroenterology 2009;104(12):3081-3.
2009: Alexander C Ford; Brennan M R Spiegel; Nicholas J Talley; Paul Moayyedi
Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009;7(12):1279-86.
2009: Alexander C Ford; Paul Moayyedi
Redundant data in the meta-analysis on Helicobacter pylori eradication.
Annals of internal medicine 2009;151(7):513; author reply 513-4.
2009: Alexander C Ford; Nicholas J Talley; Eamonn M M Quigley; Paul Moayyedi
Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials.
Diseases of the colon and rectum 2009;52(10):1805; author reply 1806.
2009: Clara K Chow; Paul Moayyedi; Philip J Devereaux
Is it safe to use a proton pump inhibitor with clopidogrel?
Polskie Archiwum Medycyny Wewnętrznej 2009;119(9):564-8.
2009: Alexander C Ford; Paul Moayyedi
Managing dyspepsia.
Current gastroenterology reports 2009;11(4):288-94.
2009: Alexander C Ford; Lawrence J Brandt; Christine Young; William Chey; Amy E Foxx-Orenstein; Paul Moayyedi
Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis.
The American journal of gastroenterology 2009;104(7):1831-43; quiz 1844.
2009: A C Ford; E Ching; Paul Moayyedi
Meta-analysis: yield of diagnostic tests for coeliac disease in dyspepsia.
Alimentary pharmacology & therapeutics 2009;30(1):28-36.
2009: Alexander C Ford; Paul Moayyedi
Should we step-up or step-down in the treatment of new-onset dyspepsia in primary care?
Polskie Archiwum Medycyny Wewnętrznej 2009;119(6):391-6.
2009: Alexander C Ford; William Chey; Nicholas J Talley; Ashish Malhotra; Brennan M R Spiegel; Paul Moayyedi
Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis.
Archives of internal medicine 2009;169(7):651-8.
2009: Paul Moayyedi; Daniel C Sadowski
Proton pump inhibitors and clopidogrel - hazardous drug interaction or hazardous interpretation of data?
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2009;23(4):251-2.
2009: A C Ford; Nicholas J Talley; Philip Schoenfeld; E M M Quigley; Paul Moayyedi
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis.
Gut 2009;58(3):367-78.
2009: Grigorios I Leontiadis; Paul Moayyedi; Alexander Charles Ford
Helicobacter pylori infection.
Clinical evidence 2009;2009():.
2009: Brendan Delaney; Alex C Ford; David Forman; Paul Moayyedi; Michelle Qume
WITHDRAWN: Initial management strategies for dyspepsia.
Cochrane database of systematic reviews (Online) 2009;(4):CD001961.
2009: Alexander C Ford; Paul Moayyedi
Bran and irritable bowels. Bran's deleterious effects: much ado about nothing.
BMJ (Clinical research ed.) 2009;339():b3956.
2009: Alexander C Ford; Paul Moayyedi
Treatment of chronic gastro-oesophageal reflux disease.
BMJ (Clinical research ed.) 2009;339():b2481.
2008: Alexander C Ford; Peter Malfertheiner; Monique Giguere; Jose Santana; Mostafizur Khan; Paul Moayyedi
Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis.
World journal of gastroenterology : WJG 2008;14(48):7361-70.
2008: A C Ford; Sander Veldhuyzen van Zanten; C C Rodgers; N J Talley; Nimish Vakil; Paul Moayyedi
Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis.
Gut 2008;57(11):1545-53.
2008: Alexander C Ford; Nicholas J Talley; Sander J O Veldhuyzen van Zanten; Nimish B Vakil; David L Simel; Paul Moayyedi
Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms?
JAMA : the journal of the American Medical Association 2008;300(15):1793-805.
2008: Alexander C Ford; David Forman; Alastair G Bailey; A T R Axon; Paul Moayyedi
Fluctuation of gastrointestinal symptoms in the community: a 10-year longitudinal follow-up study.
Alimentary pharmacology & therapeutics 2008;28(8):1013-20.
2008: Paul Moayyedi
Hip fracture and proton pump inhibitor therapy: position statement.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2008;22(10):855-8.
2008: Paul Moayyedi; Ann Cranney
Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm.
The American journal of gastroenterology 2008;103(10):2428-31.
2008: Paul Moayyedi
The epidemiology of obesity and gastrointestinal and other diseases: an overview.
Digestive diseases and sciences 2008;53(9):2293-9.
2008: A C Ford; Paul Moayyedi; D E Jarbol; R F A Logan; Brendan Delaney
Meta-analysis: Helicobacter pylori'test and treat' compared with empirical acid suppression for managing dyspepsia.
Alimentary pharmacology & therapeutics 2008;28(5):534-44.
2008: Debasish Das; Savid Ishaq; Rebecca Harrison; Kiran Kosuri; Edward Harper; John Decaestecker; Richard Sampliner; Stephen Attwood; Hugh Barr; Peter Watson; Paul Moayyedi; Janusz Jankowski
Management of Barrett's esophagus in the UK: overtreated and underbiopsied but improved by the introduction of a national randomized trial.
The American journal of gastroenterology 2008;103(5):1079-89.
2008: Alexander C Ford; David Forman; Alastair G Bailey; A T R Axon; Paul Moayyedi
Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior.
The American journal of gastroenterology 2008;103(5):1229-39; quiz 1240.
2008: Brendan Delaney; Michelle Qume; Paul Moayyedi; Richard F A Logan; Alexander C Ford; Cathy Elliott; Cliodna McNulty; Sue Wilson; F D Richard Hobbs
Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial).
BMJ (Clinical research ed.) 2008;336(7645):651-4.
2008: Nicholas J Talley; Kwong Ming Fock; Paul Moayyedi
Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer.
The American journal of gastroenterology 2008;103(3):510-4.
2008: Kwong Ming Fock; Nick Talley; Paul Moayyedi; Richard Hunt; Takeshi Azuma; Kentaro Sugano; Shu Dong Xiao; Shiu Kum Lam; Khean-Lee Goh; Tsutomu Chiba; Naomi Uemura; Jae G Kim; Nayoung Kim; Tiing Leong Ang; Varocha Mahachai; Hazel Mitchell; Abdul Aziz Rani; Jyh Ming Liou; Ratha-Korn Vilaichone; Jose Sollano
Asia-Pacific consensus guidelines on gastric cancer prevention.
Journal of gastroenterology and hepatology 2008;23(3):351-65.
2008: Paul Moayyedi; N Burch; Noori Akhtar-Danesh; S K Enaganti; R Harrison; N J Talley; J Jankowski
Mortality rates in patients with Barrett's oesophagus.
Alimentary pharmacology & therapeutics 2008;27(4):316-20.
2008: Paul Moayyedi
Barrett's esophagus and obesity: the missing part of the puzzle.
The American journal of gastroenterology 2008;103(2):301-3.
2008: Frances Tse; Louis Liu; Alan N Barkun; David Armstrong; Paul Moayyedi
EUS: a meta-analysis of test performance in suspected choledocholithiasis.
Gastrointestinal endoscopy 2008;67(2):235-44.
2008: Alexander C Ford; Nicholas J Talley; Brennan M R Spiegel; Amy E Foxx-Orenstein; Lawrence Schiller; Eamonn M M Quigley; Paul Moayyedi
Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis.
BMJ (Clinical research ed.) 2008;337():a2313.
2008: Paul Moayyedi
Economic reflections on proton pump inhibitor therapy for non-erosive reflux disease.
Digestion 2008;78 Suppl 1():61-9.
2008: Irvin M Modlin; Richard H Hunt; Peter Malfertheiner; Paul Moayyedi; Eamon M Quigley; Guido N J Tytgat; Jan Tack; Gerald Holtmann; Steven F Moss
Non-erosive reflux disease--defining the entity and delineating the management.
Digestion 2008;78 Suppl 1():1-5.
2008: Alexander C Ford; Paul Moayyedi
Current guidelines for dyspepsia management.
Digestive diseases (Basel, Switzerland) 2008;26(3):225-30.
2008: Pelham M Barton; Paul Moayyedi; Nicholas J Talley; Nimish B Vakil; Brendan Delaney
A second-order simulation model of the cost-effectiveness of managing dyspepsia in the United States.
Medical decision making : an international journal of the Society for Medical Decision Making 2008;28(1):44-55.
2007: Grigorios Leontiadis; A Sreedharan; S Dorward; Pelham M Barton; Brendan Delaney; Colin Howden; M Orhewere; J Gisbert; V K Sharma; A Rostom; Paul Moayyedi; David Forman
Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Health technology assessment (Winchester, England) 2007;11(51):iii-iv, 1-164.
2007: Alexander C Ford; David Forman; Alastair G Bailey; Karen J Goodman; A T R Axon; Paul Moayyedi
Effect of sibling number in the household and birth order on prevalence of Helicobacter pylori: a cross-sectional study.
International journal of epidemiology 2007;36(6):1327-33.
2007: Alexander C Ford; David Forman; J Nathan; Will Crocombe; A T R Axon; Paul Moayyedi
Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use.
Alimentary pharmacology & therapeutics 2007;26(9):1267-75.
2007: Paul Moayyedi
Should triple therapy for Helicobacter pylori eradication be prescribed for 1 week or 2 weeks?
Nature clinical practice. Gastroenterology & hepatology 2007;4(11):596-7.
2007: Paul Moayyedi
Sequential regimens for Helicobacter pylori eradication.
Lancet 2007;370(9592):1010-2.
2007: Jennifer Leonard; John K Marshall; Paul Moayyedi
Systematic review of the risk of enteric infection in patients taking acid suppression.
The American journal of gastroenterology 2007;102(9):2047-56; quiz 2057.
2007: Paul Moayyedi
Colorectal cancer screening lacks evidence of benefit.
Cleveland Clinic journal of medicine 2007;74(8):545, 549-50, 552 passim.
2007: Paul Moayyedi
Review: eradication therapy supplemented by probiotics increased eradication rates and reduced side effects in H pylori infection.
Evidence-based medicine 2007;12(3):84.
2007: Rebecca Harrison; Ian Perry; William Haddadin; Stuart McDonald; Richard Bryan; Keith Abrams; Richard E Sampliner; Nicholas J Talley; Paul Moayyedi; Janusz A Jankowski
Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies.
The American journal of gastroenterology 2007;102(6):1154-61.
2007: Paul Moayyedi
The promises and perils of nurse-led flexible sigmoidoscopy screening.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2007;21(5):280-2.
2007: Paul Moayyedi
Review: eradication therapy supplemented by probiotics increased eradication rates and reduced side effects in H. pylori infection.
ACP journal club 2007;146(3):63.
2007: Alexander C Ford; David Forman; Alastair G Bailey; Michael B Cook; A T R Axon; Paul Moayyedi
Who consults with dyspepsia? Results from a longitudinal 10-yr follow-up study.
The American journal of gastroenterology 2007;102(5):957-65.
2007: P Paré; Ronald Bridges; Malcolm C Champion; Subhas C Ganguli; James R Gray; E Jan Irvine; Victor Plourde; Pierre Poitras; Geoffrey K Turnbull; Paul Moayyedi; Nigel Flook; Stephen Collins
Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2007;21 Suppl B():3B-22B.
2007: Paul Moayyedi; Joshua Tepper; Robert J Hilsden; Linda Rabeneck
International comparisons of manpower in gastroenterology.
The American journal of gastroenterology 2007;102(3):478-81.
2007: Alexander C Ford; David Forman; Alastair G Bailey; A T R Axon; Paul Moayyedi
Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study.
Gut 2007;56(3):321-7.
2007: A Fraser; Brendan Delaney; Alexander C Ford; Michelle Qume; Paul Moayyedi
The Short-Form Leeds Dyspepsia Questionnaire validation study.
Alimentary pharmacology & therapeutics 2007;25(4):477-86.
2007: Brendan Delaney; Paul Moayyedi; David Forman; Cliodna McNulty
Helicobacter pylori infection.
Clinical evidence 2007;2007():.
2007: Mostafizur Khan; Jose Santana; Clare Donnellan; Cathryn Preston; Paul Moayyedi
Medical treatments in the short term management of reflux oesophagitis.
Cochrane database of systematic reviews (Online) 2007;(2):CD003244.
2007: Paul Moayyedi
The health economics of Helicobacter pylori infection.
Best practice & research. Clinical gastroenterology 2007;21(2):347-61.
2006: Nimish Vakil; Paul Moayyedi; M Brian Fennerty; Nicholas J Talley
Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis.
Gastroenterology 2006;131(2):390-401; quiz 659-60.
2006: Paul Moayyedi; Nicholas J Talley
Gastro-oesophageal reflux disease.
Lancet 2006;367(9528):2086-100.
2006: Paul Moayyedi; Nicholas J Talley; M Brian Fennerty; Nimish Vakil
Can the clinical history distinguish between organic and functional dyspepsia?
JAMA : the journal of the American Medical Association 2006;295(13):1566-76.
2006: Paul Moayyedi; Edgar Achkar
Does fecal occult blood testing really reduce mortality? A reanalysis of systematic review data.
The American journal of gastroenterology 2006;101(2):380-4.
2006: Edgar Achkar; Paul Moayyedi
Colorectal cancer screening with fecal occult blood testing (FOBT): an international perspective.
The American journal of gastroenterology 2006;101(2):212.
2006: S Dorward; A Sreedharan; Grigorios Leontiadis; Colin Howden; Paul Moayyedi; David Forman
Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding.
Cochrane database of systematic reviews (Online) 2006;(4):CD005415.
2006: Paul Moayyedi; S Soo; J Deeks; Brendan Delaney; Michael Innes; David Forman
Pharmacological interventions for non-ulcer dyspepsia.
Cochrane database of systematic reviews (Online) 2006;(4):CD001960.
2006: Hugh Barr; Catherine Kendall; Florain Bazant-Hegemark; Paul Moayyedi; G Shetty; Nicholas Stone
Endoscopic screening and surveillance for Barrett's esophagus--clinical implications.
MedGenMed : Medscape general medicine 2006;8(2):88.
2006: Hugh Barr; Catherine Kendall; Florian Bazant-Hegemark; Paul Moayyedi; G Shetty; Nicholas Stone
Endoscopic screening and surveillance for Barrett's esophagus--clinical implications.
MedGenMed : Medscape general medicine 2006;8(2):66.
2006: Alexander C Ford; Brendan Delaney; David Forman; Paul Moayyedi
Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.
Cochrane database of systematic reviews (Online) 2006;(2):CD003840.
2006: Paul Moayyedi; S Soo; J Deeks; Brendan Delaney; A Harris; Michael Innes; R A L Oakes; Sue Wilson; A Roalfe; Cathy Bennett; David Forman
Eradication of Helicobacter pylori for non-ulcer dyspepsia.
Cochrane database of systematic reviews (Online) 2006;(2):CD002096.
2006: Janusz Jankowski; John deCaestecker; Rebecca Harrison; Peter Watson; Hugh Barr; Stephen Attwood; Paul Moayyedi
NSAID and oesophageal adenocarcinoma: randomised trials needed to correct for bias.
The lancet oncology 2006;7(1):7-8; author reply 8-9.
2005: Paul Moayyedi; Brendan Delaney; David Forman
Gastro-oesophageal reflux disease.
Clinical evidence 2005;(14):567-81.
2005: Alexander C Ford; David Forman; Alastair G Bailey; A T R Axon; Paul Moayyedi
A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial.
Gastroenterology 2005;129(6):1910-7.
2005: Nicholas J Talley; Nimish Vakil; Paul Moayyedi
American gastroenterological association technical review on the evaluation of dyspepsia.
Gastroenterology 2005;129(5):1756-80.
2005: Peter Malfertheiner; Pentti Sipponen; Michael Naumann; Paul Moayyedi; Francis Mégraud; Shu-Dong Xiao; Kentaro Sugano; Olof Nyrén
Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique.
The American journal of gastroenterology 2005;100(9):2100-15.
2005: Alexander C Ford; David Forman; P Dominic Reynolds; Brian T Cooper; Paul Moayyedi
Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett's esophagus.
American journal of epidemiology 2005;162(5):454-60.
2005: Paul Moayyedi; A T R Axon
Review article: gastro-oesophageal reflux disease--the extent of the problem.
Alimentary pharmacology & therapeutics 2005;22 Suppl 1():11-9.
2005: Paul Moayyedi
Should we test for Helicobacter pylori before treating gastroesophageal reflux disease?
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2005;19(7):425-7.
2005: Sanjiv Mahadeva; M C Raman; Alexander C Ford; M Follows; A T R Axon; Khean-Lee Goh; Paul Moayyedi
Gastro-oesophageal reflux is more prevalent in Western dyspeptics: a prospective comparison of British and South-East Asian patients with dyspepsia.
Alimentary pharmacology & therapeutics 2005;21(12):1483-90.
2005: Brendan Delaney; Paul Moayyedi; David Forman
Helicobacter pylori infection.
Clinical evidence 2005;(13):518-34.
2005: Alexander C Ford; Michelle Qume; Paul Moayyedi; Nicolaas L A Arents; Annmarie T Lassen; Richard F A Logan; Kenneth E L McColl; Paul Myres; Brendan Delaney
Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis.
Gastroenterology 2005;128(7):1838-44.
2005: Filippo Cremonini; James Wise; Paul Moayyedi; Nicholas J Talley
Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis.
The American journal of gastroenterology 2005;100(6):1226-32.
2005: Paul Moayyedi; Nicholas J Talley
Gambling with gastroesophageal reflux disease: should we worry about the QALY?
The American journal of gastroenterology 2005;100(3):534-6.
2005: Paul Moayyedi
Helicobacter pylori test-and-eradicate strategy versus early endoscopy in patients with dyspepsia.
Nature clinical practice. Gastroenterology & hepatology 2005;2(2):70-1.
2005: Adam Fraser; Brendan Delaney; Paul Moayyedi
Symptom-based outcome measures for dyspepsia and GERD trials: a systematic review.
The American journal of gastroenterology 2005;100(2):442-52.
2005: Brendan Delaney; Alexander C Ford; David Forman; Paul Moayyedi; Michelle Qume
Initial management strategies for dyspepsia.
Cochrane database of systematic reviews (Online) 2005;(4):CD001961.
2005: Paul Moayyedi; David Forman; Sara Duffett; Su Mason; Julia Brown; Will Crocombe; Richard G Feltbower; Anthony Axon
Association between Helicobacter pylori infection and adult height.
European journal of epidemiology 2005;20(5):455-65.
2005: Clare Donnellan; N Sharma; Cathryn Preston; Paul Moayyedi
Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease.
Cochrane database of systematic reviews (Online) 2005;(2):CD003245.
2005: S Soo; Paul Moayyedi; J Deeks; Brendan Delaney; M Lewis; David Forman
Psychological interventions for non-ulcer dyspepsia.
Cochrane database of systematic reviews (Online) 2005;(2):CD002301.
2005: David Armstrong; John K Marshall; Naoki Chiba; Robert Enns; Carlo A Fallone; Ronnie Fass; Roger Hollingworth; Richard H Hunt; Peter J Kahrilas; Serge Mayrand; Paul Moayyedi; William G Paterson; Daniel C Sadowski; Sander J O Veldhuyzen Van Zanten
Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2005;19(1):15-35.
2005: Paul Moayyedi; S Soo; J Deeks; Brendan Delaney; A Harris; Michael Innes; R A L Oakes; Sue Wilson; A Roalfe; Cathy Bennett; David Forman
Eradication of Helicobacter pylori for non-ulcer dyspepsia.
Cochrane database of systematic reviews (Online) 2005;(1):CD002096.
2005: Paul Moayyedi; Brendan Delaney
Measuring gastroesophageal reflux symptoms: musings from Marrakech.
The American journal of gastroenterology 2005;100(1):19-20.
2004: Brendan Delaney; Paul Moayyedi; David Forman
Helicobacter pylori infection.
Clinical evidence 2004;(12):641-58.
2004: Paul Moayyedi
Meta-analysis: Can we mix apples and oranges?
The American journal of gastroenterology 2004;99(12):2297-301.
2004: Paul Moayyedi
Should patients with GERD be screened once at least for Barrett's epithelium? Con: Patients with GERD should be screened once at least for Barrett's esophagus--medicine or magic?
The American journal of gastroenterology 2004;99(12):2293-5.
2004: Paul Moayyedi; Brendan Delaney; Nimish Vakil; David Forman; Nicholas J Talley
The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis.
Gastroenterology 2004;127(5):1329-37.
2004: Aravamuthan Sreedharan; Micheal Clough; Elaine Hemingbrough; Luigi Gatta; Douglas M Chalmers; A T R Axon; Paul Moayyedi
Cost-effectiveness and long-term impact of Helicobacter pylori 'test and treat' service in reducing open access endoscopy referrals.
European journal of gastroenterology & hepatology 2004;16(10):981-6.
2004: Alexander C Ford; Brendan Delaney; David Forman; Paul Moayyedi
Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis.
The American journal of gastroenterology 2004;99(9):1833-55.
2004: Shelly Soo; David Forman; Brendan Delaney; Paul Moayyedi
A systematic review of psychological therapies for nonulcer dyspepsia.
The American journal of gastroenterology 2004;99(9):1817-22.
2004: Brendan Delaney; Paul Moayyedi
Eradicating H pylori.
BMJ (Clinical research ed.) 2004;328(7453):1388-9.
2004: Janusz Jankowski; Paul Moayyedi
Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus.
Journal of the National Cancer Institute 2004;96(11):885-7; author reply 887.
2004: Paul Moayyedi; Brendan Delaney; David Forman
Gastro-oesophageal reflux disease.
Clinical evidence 2004;(11):583-600.
2004: Naoki Chiba; Ian M Gralnek; Paul Moayyedi; Dawn Provenzale; John M Inadomi; Andrew R Willan; Andrew H Briggs; W Ray Kim
A glossary of economic terms.
European journal of gastroenterology & hepatology 2004;16(6):563-5.
2004: Paul Moayyedi; James Mason
Cost-utility and cost-benefit analyses: how did we get here and where are we going?
European journal of gastroenterology & hepatology 2004;16(6):527-34.
2004: N Sharma; Clare Donnellan; Cathryn Preston; Brendan Delaney; G Duckett; Paul Moayyedi
A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials.
Gut 2004;53 Suppl 4():iv58-65.
2004: Paul Moayyedi; J Duffy; Brendan Delaney
New approaches to enhance the accuracy of the diagnosis of reflux disease.
Gut 2004;53 Suppl 4():iv55-7.
2004: Paul Moayyedi
Bringing science to the art of diagnosis.
Gut 2004;53(5):627-8.
2004: A Ford; Brendan Delaney; David Forman; Paul Moayyedi
Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.
Cochrane database of systematic reviews (Online) 2004;(4):CD003840.
2004: Paul Moayyedi; S Soo; J Deeks; Brendan Delaney; Michael Innes; David Forman
Pharmacological interventions for non-ulcer dyspepsia.
Cochrane database of systematic reviews (Online) 2004;(4):CD001960.
2004: Paul Moayyedi; Richard H Hunt
Helicobacter pylori public health implications.
Helicobacter 2004;9 Suppl 1():67-72.
2004: S Soo; Paul Moayyedi; J Deeks; Brendan Delaney; M Lewis; David Forman
Psychological interventions for non-ulcer dyspepsia.
Cochrane database of systematic reviews (Online) 2004;(3):CD002301.
2004: S Soo; Paul Moayyedi; J Deeks; Brendan Delaney; M Lewis; David Forman
Psychological interventions for non-ulcer dyspepsia.
Cochrane database of systematic reviews (Online) 2004;(1):CD002301.
2003: Brendan Delaney; Paul Moayyedi; David Forman
Helicobacter pylori infection.
Clinical evidence 2003;(10):535-48.
2003: Paul Moayyedi; Jon Deeks; Nicholas J Talley; Brendan Delaney; David Forman
An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews.
The American journal of gastroenterology 2003;98(12):2621-6.
2003: Brendan Delaney; Paul Moayyedi; Richard F A Logan
Dyspepsia results may not apply in primary care.
BMJ (Clinical research ed.) 2003;327(7418):811.
2003: Paul Moayyedi; Brendan Delaney; David Forman
Gastro-oesophageal reflux disease.
Clinical evidence 2003;(9):496-512.
2003: Alex Ford; Paul Moayyedi
How can the current strategies for Helicobacter pylori eradication therapy be improved?
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2003;17 Suppl B():36B-40B.
2003: Brendan Delaney; Paul Moayyedi; David Forman
Helicobacter pylori infection.
American family physician 2003;67(11):2359-60.
2003: Alexander C Ford; R J Towler; Paul Moayyedi; Douglas M Chalmers; A T R Axon
Mycophenolate mofetil in refractory inflammatory bowel disease.
Alimentary pharmacology & therapeutics 2003;17(11):1365-9.
2003: Paul Moayyedi; S Soo; J Deeks; David Forman; A Harris; Michael Innes; Brendan Delaney
Systematic review: Antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia.
Alimentary pharmacology & therapeutics 2003;17(10):1215-27.
2003: A Ford; Brendan Delaney; David Forman; Paul Moayyedi
Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.
Cochrane database of systematic reviews (Online) 2003;(4):CD003840.
2003: Brendan Delaney; Paul Moayyedi; David Forman
Initial management strategies for dyspepsia.
Cochrane database of systematic reviews (Online) 2003;(2):CD001961.
2003: Paul Moayyedi; A M Carter; David Braunholtz; Andrew J Catto
Helicobacter pylori infection in subjects with acute ischaemic stroke.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2003;35(1):16-9.
2003: Paul Moayyedi; S Soo; J Deeks; Brendan Delaney; A Harris; Michael Innes; R A L Oakes; Sue Wilson; A Roalfe; Cathy Bennett; David Forman
Eradication of Helicobacter pylori for non-ulcer dyspepsia.
Cochrane database of systematic reviews (Online) 2003;(1):CD002096.
2003: Paul Moayyedi; S Soo; J Deeks; Brendan Delaney; Michael Innes; David Forman
Pharmacological interventions for non-ulcer dyspepsia.
Cochrane database of systematic reviews (Online) 2003;(1):CD001960.
2002: Paul Moayyedi; Alex Ford
Recent developments in gastroenterology.
BMJ (Clinical research ed.) 2002;325(7377):1399-402.
2002: Brendan Delaney; Paul Moayyedi; David Forman
Helicobacter pylori infection.
Clinical evidence 2002;(8):453-68.
2002: Michael F Dixon; Nicholas P Mapstone; PM Neville; Paul Moayyedi; A T R Axon
Bile reflux gastritis and intestinal metaplasia at the cardia.
Gut 2002;51(3):351-5.
2002: Paul Moayyedi
Helping patients to help themselves: the future for management of ulcerative colitis?
Gut 2002;51(3):309-10.
2002: Brendan Delaney; Paul Moayyedi; David Forman
Helicobacter pylori infection.
Clinical evidence 2002;(7):414-28.
2002: Paul Moayyedi; A T R Axon; Richard G Feltbower; Sara Duffett; Will Crocombe; David Braunholtz; I D Gerald Richards; Anthony C Dowell; David Forman
Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection.
International journal of epidemiology 2002;31(3):624-31.
2002: Paul Moayyedi
Helicobacter pylori test and treat strategy for young dyspeptic patients: new data.
Gut 2002;50 Suppl 4():iv47-50.
2002: Paul Moayyedi; J Mason
Clinical and economic consequences of dyspepsia in the community.
Gut 2002;50 Suppl 4():iv10-2.
2002: Paul Moayyedi; Jonathan Deeks; David Forman
Helicobacter pylori eradication therapy for nonulcer dyspepsia.
Annals of internal medicine 2002;136(7):555-6; author reply 555-6.
2002: Paul Moayyedi; Mark Wardman; Jeremy Toner; Mandy Ryan; Sara Duffett
Establishing patient preferences for gastroenterology clinic reorganization using conjoint analysis.
European journal of gastroenterology & hepatology 2002;14(4):429-33.
2002: Mumtaz Hayat; Robert A S Ariëns; Paul Moayyedi; Peter J Grant; Seamus O'Mahony
Coagulation factor XIII and markers of thrombin generation and fibrinolysis in patients with inflammatory bowel disease.
European journal of gastroenterology & hepatology 2002;14(3):249-56.
2002: J Mason; A T R Axon; David Forman; Sara Duffett; M Drummond; Will Crocombe; Richard G Feltbower; S Mason; J Brown; Paul Moayyedi
The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial.
Alimentary pharmacology & therapeutics 2002;16(3):559-68.
2002: Janusz A Jankowski; Dawn Provenzale; Paul Moayyedi
Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west.
Gastroenterology 2002;122(2):588-90.
2002: Paul Moayyedi; Peter Malfertheiner
Helicobacter pylori and nonmalignant disease.
Helicobacter 2002;7 Suppl 1():30-6.
2001: Michael F Dixon; PM Neville; Nicholas P Mapstone; Paul Moayyedi; A T R Axon
Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux?
Gut 2001;49(3):359-63.
2001: PM Neville; S Barrowclough; Will Crocombe; A T R Axon; Michael Wrangstadh; Paul Moayyedi
Randomised study of the efficacy of omeprazole and clarithromycin with either amoxycillin or metronidazole in the eradication of Helicobacter pylori in screened primary care patients.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2001;33(2):131-4.
2001: S Soo; Paul Moayyedi; J Deeks; Brendan Delaney; M Lewis; David Forman
Psychological interventions for non-ulcer dyspepsia.
Cochrane database of systematic reviews (Online) 2001;(4):CD002301.
2001: Brendan Delaney; Michael Innes; J Deeks; Sue Wilson; M K Cooner; Paul Moayyedi; R A L Oakes; F D Richard Hobbs; David Forman
Initial management strategies for dyspepsia.
Cochrane database of systematic reviews (Online) 2001;(3):CD001961.
2001: Paul Moayyedi; B Murphy
Helicobacter pylori: a clinical update.
Symposium series (Society for Applied Microbiology) 2001;(30):126S-33S.
2001: Paul Moayyedi; S Soo; J Deeks; Brendan Delaney; A Harris; Michael Innes; R A L Oakes; Sue Wilson; A Roalfe; Cathy Bennett; David Forman
Eradication of Helicobacter pylori for non-ulcer dyspepsia.
Cochrane database of systematic reviews (Online) 2001;(1):CD002096.
2000: Paul Moayyedi; C Wason; R Peacock; A Walan; K Bardhan; A T R Axon; Michael F Dixon
Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression.
Helicobacter 2000;5(4):206-14.
2000: Paul Moayyedi; S Soo; J Deeks; David Forman; J Mason; Michael Innes; Brendan Delaney
Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group.
BMJ (Clinical research ed.) 2000;321(7262):659-64.
2000: Paul Moayyedi; David Forman; David Braunholtz; Richard G Feltbower; Will Crocombe; M Liptrott; Anthony Axon
The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Leeds HELP Study Group.
The American journal of gastroenterology 2000;95(6):1448-55.
2000: Paul Moayyedi; Richard G Feltbower; Will Crocombe; S Mason; P Atha; J Brown; Anthony C Dowell; I D Gerald Richards; A T R Axon
The effectiveness of omeprazole, clarithromycin and tinidazole in eradicating Helicobacter pylori in a community screen and treat programme. Leeds Help Study Group.
Alimentary pharmacology & therapeutics 2000;14(6):719-28.
2000: Paul Moayyedi; Richard G Feltbower; J Brown; S Mason; J Mason; J Nathan; I D Gerald Richards; Anthony C Dowell; A T R Axon
Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group.
Lancet 2000;355(9216):1665-9.
2000: Brendan Delaney; Paul Moayyedi; S Soo; J Deeks; David Forman
Will eradication of Helicobacter pylori improve symptoms of non-ulcer dyspepsia? This meta-analysis is potentially misleading.
BMJ (Clinical research ed.) 2000;320(7243):1208-9; author reply 1210.
2000: Paul Moayyedi
Finding the optimum treatment for Helicobacter pylori.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2000;32(2):116-8.
2000: Brendan Delaney; Paul Moayyedi; J Deeks; Michael Innes; S Soo; Pelham M Barton; Sue Wilson; R A L Oakes; A Harris; James Raftery; Richard F D Hobbs; David Forman
The management of dyspepsia: a systematic review.
Health technology assessment (Winchester, England) 2000;4(39):iii-v, 1-189.
2000: Paul Moayyedi; S Soo; J Deeks; Brendan Delaney; A Harris; Michael Innes; R A L Oakes; Sue Wilson; A Roalfe; Cathy Bennett; David Forman
Eradication of helicobacter pylori for non-ulcer dyspepsia.
Cochrane database of systematic reviews (Online) 2000;(2):CD002096.
2000: Brendan Delaney; Michael Innes; J Deeks; Sue Wilson; R A L Oakes; Paul Moayyedi; F D Richard Hobbs; David Forman
Initial management strategies for dyspepsia.
Cochrane database of systematic reviews (Online) 2000;(2):CD001961.
2000: S Soo; Paul Moayyedi; J Deeks; Brendan Delaney; Michael Innes; David Forman
Pharmacological interventions for non-ulcer dyspepsia.
Cochrane database of systematic reviews (Online) 2000;(2):CD001960.
1999: Paul Moayyedi; A T R Axon
The usefulness of the likelihood ratio in the diagnosis of dyspepsia and gastroesophageal reflux disease.
The American journal of gastroenterology 1999;94(11):3122-5.
1999: Paul Moayyedi; A Zilles; Micheal Clough; E Hemingbrough; Douglas M Chalmers; A T R Axon
The effectiveness of screening and treating Helicobacter pylori in the management of dyspepsia.
European journal of gastroenterology & hepatology 1999;11(11):1245-50.
1999: Paul Moayyedi
Do young dyspeptics require endoscopy any more?
European journal of gastroenterology & hepatology 1999;11 Suppl 2():S59-62; discussion S73.
1999: D A Lynch; Nicholas P Mapstone; A M Clarke; P Jackson; Paul Moayyedi; Michael F Dixon; Philip Quirke; A T R Axon
Correlation between epithelial cell proliferation and histological grading in gastric mucosa.
Journal of clinical pathology 1999;52(5):367-71.
1999: PM Neville; Simon M Everett; H Langworthy; DS Tompkins; Nicholas P Mapstone; A T R Axon; Paul Moayyedi
The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen.
Alimentary pharmacology & therapeutics 1999;13(4):497-501.
1999: JM Mason; Paul Moayyedi; P J Young; Sara Duffett; Will Crocombe; MF Drummond; A T R Axon
Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group.
International journal of technology assessment in health care 1999;15(4):649-60.
1998: Paul Moayyedi; Sara Duffett; David Braunholtz; S Mason; I D Gerald Richards; Anthony C Dowell; A T R Axon
The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia.
Alimentary pharmacology & therapeutics 1998;12(12):1257-62.
1998: Paul Moayyedi; Michael F Dixon
Any role left for invasive tests? Histology in clinical practice.
Gut 1998;43 Suppl 1():S51-5.
1998: Paul Moayyedi; P L Ragunathan; Nicholas P Mapstone; A T R Axon; D S Tompkins
Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.
Journal of gastroenterology 1998;33(2):160-3.
1998: Paul Moayyedi; P L Ragunathan; Nicholas P Mapstone; A T R Axon; D S Tompkins
Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.
Journal of gastroenterology 1998;33 Suppl 10():62-5.
1998: Paul Moayyedi
What is the optimum strategy for managing dyspepsia?
Journal of gastroenterology 1998;33 Suppl 10():44-7.
1998: Paul Moayyedi; A T R Axon
Is there a rationale for eradication of Helicobacter pylori? Cost-benefit: the case for.
British medical bulletin 1998;54(1):243-50.
1997: Paul Moayyedi
Amoxycillin dual therapy against Helicobacter pylori--the final nail in the coffin?
Italian journal of gastroenterology and hepatology 1997;29(6):506-8.
1997: Paul Moayyedi; Seamus O'Mahony; P Jackson; D A Lynch; Michael F Dixon; A T R Axon
Small intestine in lymphocytic and collagenous colitis: mucosal morphology, permeability, and secretory immunity to gliadin.
Journal of clinical pathology 1997;50(6):527-9.
1997: Paul Moayyedi; David Braunholtz; E Heminbrough; Micheal Clough; DS Tompkins; Nicholas P Mapstone; S Mason; Anthony C Dowell; I D Gerald Richards; Douglas M Chalmers; A T R Axon
Do patients need to fast for a 13C-urea breath test?
European journal of gastroenterology & hepatology 1997;9(3):275-7.
1997: Paul Moayyedi; Douglas M Chalmers; A T R Axon
Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.
Journal of gastroenterology 1997;32(1):24-7.
1997: Paul Moayyedi; A M Carter; A Catto; R M Heppell; P J Grant; A T R Axon
Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection.
BMJ (Clinical research ed.) 1997;314(7074):119.
1997: Paul Moayyedi; M F Dixon
Significance of Helicobacter pylori infection and gastric cancer: implications for screening.
Gastrointestinal endoscopy clinics of North America 1997;7(1):47-64.
1996: Paul Moayyedi
Quadruple therapy: the golden bullet or a drug too far?
Helicobacter 1996;1(2):123-4.
1996: Paul Moayyedi; H Langworthy; K Shanahan; D S Tompkins; Michael F Dixon; Douglas M Chalmers; A T R Axon
Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori.
Helicobacter 1996;1(2):71-4.
1996: Angela M Carter; Paul Moayyedi; Andrew J Catto; R M Heppell; A T R Axon; Peter J Grant
The influence of Helicobacter pylori status on circulating levels of the coagulation factors fibrinogen, von Willebrand factor, factor VII, and factor VIII.
Helicobacter 1996;1(1):65-9.
1996: A T R Axon; Paul Moayyedi
Eradication of Helicobacter pylori: omeprazole in combination with antibiotics.
Scandinavian journal of gastroenterology. Supplement 1996;215():82-9.
1995: Paul Moayyedi; A T R Axon
Endoscopy and gastric ulcers.
Endoscopy 1995;27(9):689-93.
1995: Paul Moayyedi; S Fletcher; P Harnden; A T Axon; Aleck Brownjohn
Mesangiocapillary glomerulonephritis associated with ulcerative colitis: case reports of two patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(10):1923-4.
1995: Paul Moayyedi; P Sahay; D S Tompkins; A T R Axon
Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori.
European journal of gastroenterology & hepatology 1995;7(9):835-40.
1994: Paul Moayyedi; D S Tompkins; A T Axon
Salivary antibodies to Helicobacter pylori: screening dyspeptic patients before endoscopy.
Lancet 1994;344(8928):1016-7.